Related references
Note: Only part of the references are listed.Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
Gaelle Picarda et al.
CLINICAL CANCER RESEARCH (2010)
SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification
Takako Hattori et al.
DEVELOPMENT (2010)
COX-2 expression in chondrosarcoma: A role for celecoxib treatment?
Y. M. Schrage et al.
EUROPEAN JOURNAL OF CANCER (2010)
Molecular Characterization of Commonly Used Cell Lines for Bone Tumor Research: A Trans-European EuroBoNet Effort
Laura Ottaviano et al.
GENES CHROMOSOMES & CANCER (2010)
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
Judith V. M. G. Bovee et al.
NATURE REVIEWS CANCER (2010)
Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells
Benedicte Brounais et al.
BONE (2009)
The dual role of IL-6-type cytokines on bone remodeling and bone tumors
Frederic Blanchard et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
Yvonne M. Schrage et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2
Alexander B. Mohseny et al.
JOURNAL OF PATHOLOGY (2009)
Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells
Aline Lacreusette et al.
JOURNAL OF PATHOLOGY (2009)
A Novel Distal Enhancer Mediates Cytokine Induction of Mouse Rankl Gene Expression
Kathleen A. Bishop et al.
MOLECULAR ENDOCRINOLOGY (2009)
Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of midostaurin in vivo
Benedicte Brounais et al.
CLINICAL CANCER RESEARCH (2008)
Endochondral ossification: How cartilage is converted into bone in the developing skeleton
E. J. Mackie et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma
S. Boeuf et al.
JOURNAL OF PATHOLOGY (2008)
Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes
A. Lacreusette et al.
JOURNAL OF PATHOLOGY (2008)
The clinical approach towards chondrosarcoma
Hans Gelderblom et al.
ONCOLOGIST (2008)
Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2
Michihiko Usui et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration
Danielle J. Behonick et al.
PLOS ONE (2007)
Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53
C. Chipoy et al.
ONCOGENE (2007)
Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes
Mohammed El Mabrouk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures
Ursula Fearon et al.
ARTHRITIS AND RHEUMATISM (2006)
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival
Francois Gouin et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage
K Kishimoto et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2006)
Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes - Implications for cartilage destruction and repair
HE Barksby et al.
ARTHRITIS AND RHEUMATISM (2006)
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment
JVMG Bovée et al.
LANCET ONCOLOGY (2005)
A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL
W Hui et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Overexpression of FGFR3, Stat1, Stat5 and p21(Cip1) correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias
L Legeai-Mallet et al.
BONE (2004)
Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin m in osteosarcoma cells require PKCδ and STAT3
C Chipoy et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells
P Repovic et al.
ONCOGENE (2003)
Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M - A comparative study in gene-deficient mice
ASK de Hooge et al.
ARTHRITIS AND RHEUMATISM (2003)
Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis
P Rutkowski et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
P Palmqvist et al.
JOURNAL OF IMMUNOLOGY (2002)
Towards a new understanding and classification of chondrogenic neoplasias of the skeleton - biochemistry and cell biology of chondrosarcoma and its variants
T Aigner
VIRCHOWS ARCHIV (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Interferon-α delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases
D Murphy et al.
HEPATOLOGY (2001)
Oncostatin M and Interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells
P Klausen et al.
ONCOGENE (2000)
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
DE Levy et al.
ONCOGENE (2000)
Share Paper
